血清标志物对炎症性肠病诊断和预后评判应用进展

发布时间：2018-06-07 02:15

本文选题：血清标志物 + 炎症性肠病　；参考：《中国实用内科杂志》2015年09期

【摘要】：正炎症性肠病(inflammatory bowel disease,IBD)是一组病因尚不十分明确的累及消化道的慢性非特异性疾病,包括溃疡性结肠炎(Ulcerative colitis,UC)和克罗恩病(Crohn’s disease,CD)。诊断须综合临床表现、实验室和放射学检查、内镜及病理学检查,并在排除其他原因引起的肠道炎症基础上诊断UC和CD。但仍有近5%~15%的IBD患者病变仅累及结肠,
[Abstract]:Inflammatory bowel disease (bowel) is a group of chronic nonspecific diseases involving the digestive tract, including ulcerative colitis (UC) and Crohns disease (CDD). Diagnosis should be based on clinical manifestations, laboratory and radiologic examination, endoscopy and pathology, and the diagnosis of UC and CD on the basis of the exclusion of intestinal inflammation caused by other causes. But there are still nearly 5% of IBD patients with lesions only involved in the colon,
【作者单位】：中国医学科学院北京协和医学院北京协和医院;
【分类号】：R574

【参考文献】